prevailtherapeutics.com

Prevail Therapeutics

Prevail Therapeutics's email is info@prevailtherapeutics.com .

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, and OrbiMed, and is headquartered in New York, NY.
View Top Employees for Prevail Therapeutics
img Website prevailtherapeutics.com
img Industry Biotechnology
img Location New York, United States
img Employees 64
img Founded 2017
img Email info@prevailtherapeutics.com
img Funding 129,000,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website prevailtherapeutics.com
img Industry Biotechnology
img Location New York, United States
img Employees 64
img Founded 2017
img LinkedIn linkedin.com/company/prevail-therapeutics
img Email info@prevailtherapeutics.com
img Funding 129,000,000 USD

Top Prevail Therapeutics Employees